{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:47:46Z","timestamp":1787316466760,"version":"build-2736575974"},"reference-count":93,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1584,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1529-8019.2011.01419.x","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T10:07:50Z","timestamp":1308564470000},"page":"355-363","source":"Crossref","is-referenced-by-count":36,"title":["Topical and intralesional therapies for alopecia areata"],"prefix":"10.1155","volume":"24","author":[{"given":"ABDULLAH","family":"ALKHALIFAH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,20]]},"reference":[{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","article-title":"Alopecia areata","volume":"46","author":"Wasserman","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1111\/1523-1747.ep12471869","article-title":"Alopecia areata: clinical aspects","volume":"96","author":"Price","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0190-9622(00)90164-6","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archderm.139.12.1555","article-title":"Histopathologic features of alopecia areata: a new look","volume":"139","author":"Whiting","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940601101X","article-title":"Alopecia areata: pathogenesis and potential for therapy","volume":"8","author":"Lu","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB8|cit8","first-page":"541","article-title":"Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?","volume":"66","author":"Paus","year":"1993","journal-title":"Yale J Biol Med"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update: part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines - Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000252466","article-title":"Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of the ensuing localized acneform response","volume":"141","author":"Pascher","year":"1970","journal-title":"Dermatologica"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.2003.01862.x","article-title":"Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial","volume":"42","author":"Mancuso","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis\/universalis","volume":"49","author":"Tosti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1468-3083.2006.01781.x","article-title":"Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial","volume":"20","author":"Tosti","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archderm.136.10.1276","article-title":"Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream","volume":"136","author":"Charuwichitratana","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sder.2008.12.002","article-title":"Alopecia areata: evidence-based treatments","volume":"28","author":"Garg","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB17|cit17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004413.pub2","article-title":"Interventions for alopecia areata","volume":"2","author":"Delamere","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","article-title":"Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector","volume":"88","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2133.1971.tb07230.x","article-title":"A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata","volume":"85","author":"Porter","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB20|cit20","first-page":"674","article-title":"Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs","volume":"71","author":"Kubeyinje","year":"1994","journal-title":"East Afr Med J"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB21|cit21","first-page":"909","article-title":"Treatment of severe alopecia areata with intralesional steroid injections","volume":"8","author":"Chang","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0733-8635(05)70017-6","article-title":"Hair regrowth. Therapeutic agents","volume":"16","author":"Shapiro","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bbrc.2007.03.065","article-title":"Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells","volume":"356","author":"Sohn","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1523-1747.ep12261084","article-title":"Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography","volume":"82","author":"Wester","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.1987.tb07505.x","article-title":"Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia","volume":"117","author":"Bunker","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0190-9622(87)70084-X","article-title":"Action of topical minoxidil in the bald stump-tailed macaque","volume":"16","author":"Uno","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1346-8138.1990.tb01641.x","article-title":"The effect of topical minoxidil on hair follicular cycles of rats","volume":"17","author":"Mori","year":"1990","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1523-1747.ep12499788","article-title":"Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo","volume":"98","author":"Buhl","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","author":"Fiedler-Weiss","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archderm.122.2.180","article-title":"Topical minoxidil dose-response effect in alopecia areata","volume":"122","author":"Fiedler-Weiss","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0906-6705.2004.00098.x","article-title":"Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin","volume":"13","author":"Tang","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archderm.115.10.1254","article-title":"Treatment of alopecia areata by anthralin-induced dermatitis","volume":"115","author":"Schmoeckel","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archderm.123.11.1491","article-title":"Evaluation of anthralin in the treatment of alopecia areata","volume":"123","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archderm.126.6.756","article-title":"Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin","volume":"126","author":"Fiedler","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00128071-200506060-00007","article-title":"Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study","volume":"6","author":"Sasmaz","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00293811","article-title":"Mutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE)","volume":"45","author":"Strobel","year":"1980","journal-title":"Arch Toxicol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1218(80)90124-X","article-title":"1-chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium","volume":"77","author":"Summer","year":"1980","journal-title":"Mutat Res"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0190-9622(84)80456-9","article-title":"Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability","volume":"11","author":"Wilkerson","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0190-9622(85)70164-8","article-title":"Squaric acid and esters: analysis for contaminants and stability in solvents","volume":"13","author":"Wilkerson","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00416931","article-title":"Antigenic competition as a therapeutic concept for alopecia areata","volume":"267","author":"Happle","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB47|cit47","first-page":"537","article-title":"Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes","volume":"16","author":"Herbst","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00412926","article-title":"Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata","volume":"278","author":"Happle","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasylyszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1523-1747.ep12395722","article-title":"Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone","volume":"103","author":"Hoffmann","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"c3671","DOI":"10.1136\/bmj.c3671","article-title":"Management of alopecia areata","volume":"341","author":"Harries","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB53|cit53","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1525-1470.1994.tb00078.x","article-title":"Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients","volume":"11","author":"Orecchia","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1038\/jid.1995.53","article-title":"Topical immunotherapy in children with alopecia areata","volume":"104","author":"Orecchia","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1991.tb00643.x","article-title":"Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not","volume":"124","author":"Orecchia","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630410023601","article-title":"Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial","volume":"16","author":"Dall'oglio","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.1996.tb06317.x","article-title":"Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up","volume":"134","author":"Gordon","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB59|cit59","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1034\/j.1600-0536.2002.4705102.x","article-title":"Urticaria after topical immunotherapy with diphenylcyclopropenone","volume":"47","author":"Francomano","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(99)70540-2","article-title":"Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata","volume":"40","author":"Alam","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0536.1989.tb04737.x","article-title":"Contact urticaria during topical immunotherapy","volume":"21","author":"Tosti","year":"1989","journal-title":"Contact Dermatitis"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000247976","article-title":"Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone","volume":"180","author":"Perret","year":"1990","journal-title":"Dermatologica"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.47102\/annals-acadmedsg.V38N3p276","article-title":"Vitiligo as an adverse reaction to topical diphencyprone","volume":"38","author":"Pan","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2133.1995.tb02692.x","article-title":"Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis","volume":"133","author":"Henderson","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.IOP.0000132175.30732.74","article-title":"Trichiasis associated with prostaglandin analog use","volume":"20","author":"Bearden","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.jaad.2004.05.002","article-title":"Hypertrichosis of the eyelashes caused by bimatoprost","volume":"51","author":"Tosti","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajo.2003.09.002","article-title":"Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost","volume":"137","author":"Hart","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1468-3083.2004.01020.x","article-title":"Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost","volume":"18","author":"Herane","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0906-6705.2005.00270.x","article-title":"Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicularmelanogenesis in a murine model","volume":"14","author":"Sasaki","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","article-title":"Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata","volume":"60","author":"Roseborough","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","article-title":"Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata","volume":"53","author":"Ross","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB73|cit73","first-page":"586","article-title":"The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows","volume":"19","author":"Faghihi","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2009.03543.x","article-title":"Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis","volume":"24","author":"Coronel-Perez","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2009.01.027","article-title":"Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata","volume":"61","author":"Ochoa","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","article-title":"PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology","volume":"133","author":"Taylor","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2133.1993.tb03309.x","article-title":"PUVA treatment for alopecia areata - does it work? A retrospective review of 102 cases","volume":"129","author":"Healy","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","article-title":"308-nm excimer laser therapy in alopecia areata","volume":"51","author":"Zakaria","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1610-0387.2005.05710.x","article-title":"Excimer laser therapy of alopecia areata - side-by-side evaluation of a representative area","volume":"3","author":"Raulin","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/lsm.20002","article-title":"Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser","volume":"34","author":"Gundogan","year":"2004","journal-title":"Lasers Surg Med"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","article-title":"308-nm excimer laser for the treatment of alopecia areata","volume":"33","author":"Al-Mutairi","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1525-1470.2009.00980.x","article-title":"308-nm excimer laser for the treatment of alopecia areata in children","volume":"26","author":"Al-Mutairi","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"592 e1","DOI":"10.1016\/j.jaad.2009.02.037","article-title":"Phase I\/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata","volume":"61","author":"Talpur","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1468-3083.2009.03243.x","article-title":"Capsaicin versus clobetasol for the treatment of localized alopecia areata","volume":"23","author":"Ehsani","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2230.2007.02367.x","article-title":"Lack of response of alopecia areata to pimecrolimus cream","volume":"32","author":"Rigopoulos","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2133.2002.500210.x","article-title":"Is topical tacrolimus effective in alopecia areata universalis?","volume":"147","author":"Feldmann","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/000155502320624203","article-title":"Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis","volume":"82","author":"Park","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-4632.2008.03327.x","article-title":"Lack of efficacy of topical imiquimod in the treatment of patchy alopecia areata","volume":"47","author":"Koc","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1468-3083.2002.00570_4.x","article-title":"Ineffectiveness of imiquimod therapy for alopecia totalis\/universalis","volume":"16","author":"D'Ovidio","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2000.03783.x","article-title":"Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata","volume":"143","author":"Bissonnette","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2011.01419.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2230.2008.02712.x","article-title":"Failure to treat alopecia areata with photodynamic therapy","volume":"33","author":"Fernandez-Guarino","year":"2008","journal-title":"Clin Exp Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2011.01419.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2011.01419.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T10:50:48Z","timestamp":1686135048000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2011.01419.x"}},"subtitle":["Therapies for alopecia areata"],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2011.01419.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}